MEDICAL INTELLIGENCE UNIT PROTEIN AND AMINO ACID METABOLISM IN CANCER CACHEXIA Peter W.T. Pisters University of Texas M.D. Anderson Cancer Center Houston, Texas, U.S.A. Murray F. Brennan Memorial Sloan-Kettering Cancer Center New York, New York, U.S.A. Springer-Verlag Berlin Heidelberg GmbH MEDICAL INTELLIGENCE UNIT PROTEIN AND AMINO ACID METABOLISM IN CANCER CACHEXIA R.G. LANDES COMPANY Austin, Texas, U.S.A. International Copyright © 1996 Springer-Verlag Berlin Heidelberg Originally published by Springer-Verlag in 1996 Softcover reprint of the hardcover 1st edition 1996 All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, elec tronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. 'Spring" International ISBN 978-3-662-22348-2 While the authors, editors and publisher believe that drug selection and dosage and the specifications and usage of equipment and devices, as set forth in this book, are in accord with current recommend ations and practice at the time of publication, they make no warranty, expressed or implied, with respect to material described in this book. In view of the ongoing research, equipment development, changes in governmental regulations and the rapid accumulation of information relating to the biomedical sciences, the reader is urged to carefully review and evaluate the information provided herein. Library of Congress Cataloging-in-Publication Data Protein and amino acid metabolism in cancer cachexial[edited by} Peter W.T. Pisters, Murray F. Brennan. p. em. - (Medical intelligence unit) Includes bibliographical references and index. ISBN 978-3-662-22348-2 ISBN 978-3-662-22346-8 (eBook) DOI 10.1007/978-3-662-22346-8 1. Proteins- Metabolism-Disorders. 2. Amino acids-Metabolism-Disorders. 3. Cachexia. 4. Cancer- Complications. 5. Cancer-Nutritional aspects. 6. Anorexia. I. Pisters, Peter W.T., 1960-. II. Brennan, Murray F. III. Series. [DNLM: 1. Cachexia-metabolism. 2. Cachexia-therapy. 3. Neoplasms--complications. 4. Proteins-metabolism. 5. Amino acids-metabolism. WB 146 P967 1995} RC632.P7P76 1995 616. 99'4-dc20 DNLM/DLC 95-24641 for Library of Congress CIP NoTE PuBLISHER's R.G. Landes Company publishes six book series: Medical Intelligence Unit, Molecular Biology Intelligence Unit, Neuroscience Intelligence Unit, Tissue Engineering Intelligence Unit, Biotechnology Intelligence Unit and Environmental Intelligence Unit. The authors of our books are acknowledged leaders in their fields and the topics are unique. Almost without exception, no other similar books exist on these topics. Our goal is to publish books in important and rapidly changing areas of bioscience and environment for sophisticated researchers and clinicians. To achieve this goal, we have accelerated our publishing program to conform to the fast pace in which information grows in bioscience. Most ofo ur books are published within 90 to 120 days of receipt of the manuscript. We would like to thank our readers for their continuing interest and welcome any comments or suggestions they may have for future books. Deborah Muir Molsberry Publications Director R. G. Landes Company CONTENTS========;-] r;:::::::===== 1. Animal Models of Cancer Cachexia ............................................ 1 Lawrence E. Harrison Introduction ......................................................................................... 1 Tumor Models ...................................................................................... 2 Rat ........................................................................................................ 4 Mechanisms of Cancer Cachexia ........................................................... 6 Abnormalities in Host Metabolism ....................................................... 7 Therapeutic Intervention .................................................................... 13 Insulin ................................................................................................ 13 Conclusion .......................................................................................... 14 2. Non-Invasive Techniques to Evaluate Protein and Amino Acid Metabolism .................................................... 21 RussellS. Berman History and Anthropometric Measurements ....................................... 21 Serum Proteins .................................................................................... 23 Nitrogen Balance Studies .................................................................... 23 3-Methylhistidine Excretion ................................................................ 24 Body Composition Analysis ................................................................ 25 3. Invasive Techniques to Evaluate Protein and Amino Acid Metabolism: Regional and Whole Body Amino Acid Kinetic Studies ............ 33 RussellS. Berman Regional Protein and Amino Acid Metabolism ................................... 33 Whole Body Protein Metabolism ........................................................ 39 4. Cytokines in Cancer Cachexia .................................................. 51 Kevin G. Billingsley and H Richard Alexander Introduction ....................................................................................... 51 Cytokines and Cachexia ...................................................................... 53 Tumor Necrosis Factor ....................................................................... 54 lnterleukin-1 ....................................................................................... 61 Interferon GAMMA ........................................................................... 63 lnterleukin-6 ....................................................................................... 63 Leukemia Inhibitory Factor ................................................................. 65 Conclusion .......................................................................................... 66 5. Plasma Amino Acid Concentrations in Cancer Cachexia .......... 73 Steven Hochwald and Martin J Heslin Animal Studies .................................................................................... 74 Human Studies ................................................................................... 74 6. 3-Methylhistidine and Protein Catabolism ............................... 83 David B. Pearlstone 7. Regional Amino Acid Studies in Cancer Cachexia .................... 93 Elliot Newman and Steven Hochwald Introduction ....................................................................................... 93 Studies Across Skeletal Muscle Beds .................................................... 93 Studies Involving the Liver Bed ......................................................... 102 Studies Across the Gut ...................................................................... 106 Summary .......................................................................................... 108 8. Whole Body Amino Acid Studies in Cancer Cachexia ............ 113 RussellS. Berman Amino Acid Studies .......................................................................... 113 Whole Body Kinetic Studies ............................................................. 114 Whole Body Studies and Nutritional Support ................................... 117 9. Total Parenteral Nutrition in Cancer ..................................... 123 Peter W T. Pisters and Murray F. Brennan Surgical Oncology ............................................................................. 123 Medical Oncology Patients ............................................................... 126 Radiation Oncology Patients ............................................................. 127 Summary .......................................................................................... 128 10. Enteral Nutrition in Cancer .................................................... 133 Peter W. T. Pisters and Murray F. Brennan 11. Glutamine and Cancer Cachexia ............................................. 139 Barrie P. Bode, Craig Fischer, Steven Abcouwer, Masafumi Wa sa and Wiley W. Souba Physiologic and Biochemical Importance of Glutamine .................... 140 Summary .......................................................................................... 164 12. Gluconeogenic Blockade ......................................................... 171 Steven Hochwald and Michael Burt Hydrazine Sulfate .............................................................................. 174 3-Mercaptopicolinic Acid .................................................................. 180 13. Insulin to Impact on Protein and Amino Acid Metabolism .... 187 Martin J Heslin Introduction ..................................................................................... 187 Non-Cancer Studies (animal & human) ........................................... 188 Tumor-Bearing Animal Studies ......................................................... 191 Human Cancer Studies ..................................................................... 194 14. Growth Hormone/IGF-1 ........................................................ 201 Ronald F. Wolf Introduction ..................................................................................... 201 Alterations in Metabolism of Cancer Patients .................................... 201 Metabolic Effects of Growth Hormone and IGF-1 ........................... 202 Anabolic Effects of Growth Hormone and IGF-1 in the Tumor-Bearing Host ........................................................... 204 Possible Carcinogenic Effects of Growth Hormone and IGF-1 ......... 208 Future Directions .............................................................................. 208 15. Somatostatin ........................................................................... 213 David L. Bartlett 16. Adrenergic Agents ................................................................... 227 james H. F. Shaw and jonathan B. Koea Introduction ..................................................................................... 227 The Role of Catecholamines in the Regulation of Protein Metabolism ....................................... 227 The Role of Catecholamines in the Regulation of Protein Metabolism in Cancer ................................................... 230 The Role of Sympathomimetic Agents in the Treatment of Cancer Cachexia ............................................ 233 Summary .......................................................................................... 235 17. Steroids and Progestins ........................................................... 241 Kristine Nelson Introduction ..................................................................................... 241 Progestins .......................................................................................... 241 Glucocortoids (GC) .......................................................................... 250 Anabolic Steroids (AS) ...................................................................... 257 Summary .......................................................................................... 261 Index .............................................................................................. 271 r;=:::=::===============E DI TO RS ==================il Peter W.T. Pisters, M.D. Assistant Professor of Surgical Oncology University ofTexas M.D. Anderson Cancer Center Houston, Texas, U.S.A. Chapters 9, 10 Murray F. Brennan, M.D. Department of Surgery Memorial Sloan-Kettering Cancer Center New York, New York, U.S.A. Chapters 9, 10 ~======CONTRIBUTORS========! Steven Abcouwer, Ph.D. RussellS. Berman, M.D. Division of Surgical Oncology New York University and the Nutrition Support Unit Medical Center Department of Surgery New York, New York, U.S.A. Massachusetts General Hospital Chapters 2, 3, 8 Harvard Medical School Boston, Massachusetts, U.S.A. Kevin G. Billingsley, M.D. Chapter II Surgical Metabolism Section National Cancer Institute H. Richard Alexander, M.D. Bethesda, Maryland, U.S.A. Surgical Metabolism Section Chapter 4 National Cancer Institute Bethesda, Maryland U.S.A. Barrie P. Bode, Ph.D. Chapter 4 Division of Surgical Oncology and the Nutrition Support Unit David L. Bartlett, M.D. Department of Surgery Memorial Sloan-Kettering Massachusetts General Hospital Cancer Center Harvard Medical School New York, New York, U.S.A. Boston, Massachusetts, U.S.A. Chapter I5 Chapter II
Description: